Indeed, systemic treatment using recombinant TNF-α (rTNF-α) caused CT26 tumor regression in wild-type mice with a macroscopic developmental profile similar to previously tested more complex therapies like bacteria (SL7207) or the upstream stimulant LPS (Figure 4A). The gene discussed is TNF; the disease is neoplasm.